Epic Research Update : Glenmark Pharmaceuticals

Glenmark Pharmaceuticals is set to out-license its molecule for pain management: BS

The molecule, GRC 17536, is expected to have a market potential worth USD 1 billion

Real Time News & Trading Trends Keep Liking#EpicResearch



Facebook – Twitter – YouTube – Pinterest–Linkedin – Google+



For more information ✆ – 0731-6642300 or Visithttp://www.epicresearch.co





Real Time News & Trading Trends Keep Liking #EpicResearch
Facebook – Twitter – YouTube – Pinterest –Linkedin – Google+
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co